POCT Cardiac
[POCT Cardiac]
EPTIS factsheet 1176672 | Last revision 2024-05-22 | URL: https://www.eptis.bam.de/pts1176672 https://www.eptis.bam.de/pts1176672
PT provider | |||||||||||||||||||
PT provider | Weqas Weqas | ||||||||||||||||||
Based in | United Kingdom | ||||||||||||||||||
Language(s) | |||||||||||||||||||
Remarks | Three liquid human plasma samples are distributed monthly, with a minimum of 36 samples distributed over the year covering a wide clinical range. The samples consist of a panel of linearly related samples produced from heparin plasma donations from healthy volunteers spiked with Cardiac Troponin complex, Myoglobin, and the MB isoenzyme of Creatine Kinase (CKMB). The programme includes samples that span the analytical and clinically relevant ranges. The programme accommodates POCT assays reporting quantitative and qualitative results. They are distributed on a number of occasions over the year, which allows for the assessment of the organisation’s and method’s performance, including linearity, bias, within and between batch imprecision. Key Features: - EDTA plasma samples require no pre-analytical preparation. - Linearly related panel covering a clinically relevant range. For more information: https://www.weqas.com/services/poct-eqa/poct-cardiac/ or contact@weqas.com For information on hsTroponin https://www.weqas.com/services/eqa/hs-troponin/ or contact@weqas.com | ||||||||||||||||||
Keywords | |||||||||||||||||||
Product groups |
Health care / medical devices
|
||||||||||||||||||
Testing fields |
Medical analysis
|
||||||||||||||||||
Technical details | |||||||||||||||||||
|
|||||||||||||||||||
Aims of the PT scheme | |||||||||||||||||||
Target group of participants | The Programme aims to assess the performance of organisations utilising Point of Care tests (POCT) biochemical cardiac markers to aid in the assessment of acute coronary syndrome (ACS) and cardiac ischaemia. A separate programme is available for High sensitivity cardiac Troponin T and I. | ||||||||||||||||||
Linked to specific legislation / standards | Accreditation by UKAS based on ISO/IEC 17043. | ||||||||||||||||||
Additional, subsidiary aims | validation of testing methods | ||||||||||||||||||
Number of participants | |||||||||||||||||||
Accredited or otherwise reviewed by a 3rd party |
Accredited by UKAS on the basis of ISO/IEC 17043 for part of the parameters |
||||||||||||||||||
Operation is commissioned / requested by | |||||||||||||||||||
Fees and frequency | |||||||||||||||||||
Participation fee | https://www.weqas.com/participantzone/subscription-charges/ | ||||||||||||||||||
Regularly operated | Yes (Frequency: Monthly. Samples: 3 x 0.5mL. ) | ||||||||||||||||||
Year of first operation | 2005 | ||||||||||||||||||
Contact details of the PT provider | |||||||||||||||||||
Provider | Contact person | ||||||||||||||||||
Weqas
Unit 6, Parc Ty Glas CF14 5DU Cardiff United Kingdom Phone: 44 (0) 2920 314750 Fax: Web: http://www.weqas.com http://www.weqas.com |
Laura Lloyd-Lewis
Phone: 44 (0) 29218 32884 Fax: Email: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk |